SMAD1 promoter hypermethylation and lack of SMAD1 expression in Hodgkin lymphoma: a potential target for hypomethylating drug therapy.
Gerlach MM, Stelling-Germani A, Ting Wu C, Newrzela S, Döring C, Vela V, Müller A, Hartmann S, Tzankov A. Haematologica. 2021 Feb 1; 106(2):619-621. Epub 2021 Feb 1.